Errani, F., Nai, F., Bochenkova, E., Herok, M., Invernizzi, A., Bedi, R. K., … Caflisch, A. (2026). Structure-Based Design of Potent Pan-YTHDF Ligands. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02977 (Original work published 2026)

Liu, B., Spalinger, M. R., Invernizzi, A., Gerdes, E., Steglich, B., Schwarzfischer, M., … Huber, S. (2026). Indirect Inhibition of the NLRP3-Interleukin-1β Axis Contributes to the Efficacy of JAK1 Inhibitors in Experimental Colitis and Human Ulcerative Colitis. Nature Communications, 17(1), 5429. https://doi.org/10.1038/s41467-026-71808-y (Original work published)

Invernizzi, A., Nai, F., Bedi, R. K., Vargas-Rosales, P. A., Li, Y., Bochenkova, E., … Caflisch, A. (2025). Discovery of YTHDF2 Ligands by Fragment-Based Design. ACS Bio & Med Chem Au, 5(4), 753–765. https://doi.org/10.1021/acsbiomedchemau.5c00099 (Original work published)

Errani, F., Invernizzi, A., Herok, M., Bochenkova, E., Stamm, F., Corbeski, I., … Caflisch, A. (2024). Proteolysis targeting chimera degraders of the METTL3–14 m6A-RNA methyltransferase. Journal of the American Chemical Society Au, 4(2), 713-729. https://doi.org/10.1021/jacsau.4c00040 (Original work published)

Nai, F., Flores-Espinoza, M., Invernizzi, A., Vargas-Rosales, P. A., Bobileva, O., Herok, M., & Caflisch, A. (2023). Small-molecule inhibitors of the m7G-RNA writer METTL1. ACS Bio & Med Chem Au, 4(2), 100-110. https://doi.org/10.1021/acsbiomedchemau.3c00030 (Original work published)